The cytotoxicity of
2-bromoethanol towards hepatocytes isolated from rats was concentration-dependent (EC(50)100 mu M, 2 hr).
Bromoacetaldehyde was more toxic (EC(50)60 mu M, 2 hr) and
bromoacetic acid was less toxic (EC(50)150 mu M, 2 hr).
Glutathione (GSH) depletion occurred before cytotoxicity ensued and GSH depleted hepatocytes were more susceptible to
2-bromoethanol. Lipid peroxidation increased steadily 1 hr after
2-bromoethanol addition and
antioxidants,
iron chelators or
hypoxia prevented
2-bromoethanol induced lipid peroxidation and cell lysis.
Alcohol dehydrogenase inhibitors, methyl
pyrazole or
dimethyl sulfoxide only partly prevented
2-bromoethanol induced GSH depletion, lipid peroxidation and cytotoxicity. However,
cytochrome P4502E1 (
CYP2E1) inhibitors/substrates were more effective at preventing 2-bromoethanol-induced GSH depletion, lipid peroxidation and cytotoxicity suggesting that
2-bromoethanol is mostly metabolically activated by
CYP2E1. Also, hepatocytes isolated from
CYP2E1 induced rats were more susceptible to
2-bromoethanol and hepatocytes isolated from rats pretreated with
carbon disulfide to inactivate
CYP2E1 were more resistant to
2-bromoethanol treatment. Formation of S-(formylmethyl)
glutathione during
2-bromoethanol metabolism by microsomal
mixed function oxidase in the presence of GSH was also prevented by
cytochrome P4502E1 inhibitors/substrates or by Anti-Rat
CYP2E1. Furthermore,
aldehyde dehydrogenase inhibitors-
cyanamide or
chloral hydrate increased
2-bromoethanol dependent hepatocyte susceptibility. This suggests that
2-bromoethanol is preferably metabolised by
CYP2E1 dependent monoxygenase to form
2-bromoacetaldehyde which causes cell lysis as a result of GSH depletion and lipid peroxidation.